510(k) Report

FDA applicant

Crestat Diagnostics, Inc.

Murrieta, CA29 decisions1990–19981 recall

FDA records 29 decisions for Crestat Diagnostics, Inc. (Murrieta, CA) from 1990 to 1998: 29 510(k) clearances. Most are in product codes CFN (Method, Nephelometric, Immunoglobulins (G, A, M)) and DER (Alpha-1-Lipoprotein, Antigen, Antiserum, Control). Its devices cite 5 predicates, 0 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, immunology panel, where it files most

How often FDA has decided Crestat Diagnostics, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Crestat Diagnostics, Inc. since 2007.

Recalls per year

1in 2013

2013: 1
2007high 1 (2013) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Crestat Diagnostics, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Crestat Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report